# Rockefeller Fertility Center – FDA 483, Jul 30, 2026

Source: https://www.keypedia.com/records/483/rockefeller-fertility-center/1832b8cf-1830-4d60-8fc5-83d27ab1961b

> FDA 483 for Rockefeller Fertility Center on July 30, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Rockefeller Fertility Center
- Inspection Date: 2026-07-30
- Product Type: biologics
- Office Name: New York District Office
- Summary: Rockefeller Fertility Center in New York was inspected regarding its reproductive human tissue operations. The inspection revealed significant issues with donor eligibility determinations, including incomplete testing and failure to address communicable disease risk factors. Additionally, the firm failed to properly label HCT/Ps and maintained inaccurate and illegible donor eligibility records.

## Related Documents

- [483 - 2021-11-05](https://www.keypedia.com/records/483/rockefeller-fertility-center/19530967-a004-456f-8f19-ce5f5bd91f0d) — date: November 5, 2021

## Related Officers

- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/rockefeller-fertility-center/f24a3b39-7552-41eb-b92f-50cf8970c5a0

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d